Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
Anti-CD3 x anti-CD20 bispecific antibody (CD20Bi)
Anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0051
Anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0051-LNP
Anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CEA
CEA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0052
CEA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CEA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0052-LNP
CEA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Anti-CTLA4 MoAb
Anti-CTLA4 MoAb Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0053
Anti-CTLA4 MoAb Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Anti-CTLA4 MoAb was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0053-LNP
Anti-CTLA4 MoAb Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Anti-CTLA4 MoAb RNA/GITRL RNA
Anti-CTLA4 MoAb RNA/GITRL RNA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0054
Anti-CTLA4 MoAb RNA/GITRL RNA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Anti-CTLA4 MoAb RNA/GITRL RNA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0054-LNP
Anti-CTLA4 MoAb RNA/GITRL RNA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
GnRH(22-31)
GnRH(22-31) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0055
GnRH(22-31) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding GnRH(22-31) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0055-LNP
GnRH(22-31) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Anti-idiotype MUC-1 mab
Anti-idiotype MUC-1 mab Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0056
Anti-idiotype MUC-1 mab Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Anti-idiotype MUC-1 mab was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0056-LNP
Anti-idiotype MUC-1 mab Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
mAb MK2-23
mAb MK2-23 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0057
mAb MK2-23 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding mAb MK2-23 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0057-LNP
mAb MK2-23 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Anti-Id MoAb BEC2 (Ab2)
Anti-Id MoAb BEC2 (Ab2) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0058
Anti-Id MoAb BEC2 (Ab2) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Anti-Id MoAb BEC2 (Ab2) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0058-LNP
Anti-Id MoAb BEC2 (Ab2) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
NY-ESO-1
NY-ESO-1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0059
NY-ESO-1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding NY-ESO-1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0059-LNP
NY-ESO-1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
NY-ESO-1
NY-ESO-1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0060
NY-ESO-1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding NY-ESO-1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0060-LNP
NY-ESO-1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.226151s